H J Gruss

744 total citations
13 papers, 559 citations indexed

About

H J Gruss is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, H J Gruss has authored 13 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Genetics and 3 papers in Oncology. Recurrent topics in H J Gruss's work include Chronic Lymphocytic Leukemia Research (3 papers), Immune Response and Inflammation (3 papers) and T-cell and B-cell Immunology (2 papers). H J Gruss is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Immune Response and Inflammation (3 papers) and T-cell and B-cell Immunology (2 papers). H J Gruss collaborates with scholars based in Germany, United States and Canada. H J Gruss's co-authors include H G Drexler, Robert J. Anderberg, P.C. de Vries, Stewart D. Lyman, Kenneth Brasel, Raymond G. Goodwin, F. Herrmann, Hilmar Quentmeier, Olivier Rosnet and Daniel Birnbaum and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Gastroenterology.

In The Last Decade

H J Gruss

13 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H J Gruss Germany 11 232 165 130 117 101 13 559
Volker Diehl Germany 14 164 0.7× 102 0.6× 179 1.4× 117 1.0× 146 1.4× 23 501
Marjan Daneshpouy France 9 196 0.8× 142 0.9× 172 1.3× 100 0.9× 54 0.5× 12 505
Hideaki Mizoguchi Japan 14 313 1.3× 274 1.7× 83 0.6× 194 1.7× 139 1.4× 30 703
Andreas Himmelmann Switzerland 10 211 0.9× 74 0.4× 267 2.1× 125 1.1× 158 1.6× 26 600
Junjiro Tsuchiyama Japan 14 303 1.3× 96 0.6× 218 1.7× 252 2.2× 76 0.8× 30 674
Sherry C. Huang United States 13 231 1.0× 134 0.8× 162 1.2× 233 2.0× 42 0.4× 22 677
Junko Ohata Japan 11 458 2.0× 112 0.7× 118 0.9× 140 1.2× 215 2.1× 17 718
Nora Ku United States 11 202 0.9× 250 1.5× 65 0.5× 128 1.1× 99 1.0× 24 584
Sigrid Klein Germany 16 333 1.4× 137 0.8× 133 1.0× 224 1.9× 55 0.5× 21 717
Dariusz Woszczyk Poland 12 97 0.4× 139 0.8× 77 0.6× 109 0.9× 99 1.0× 27 397

Countries citing papers authored by H J Gruss

Since Specialization
Citations

This map shows the geographic impact of H J Gruss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H J Gruss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H J Gruss more than expected).

Fields of papers citing papers by H J Gruss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H J Gruss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H J Gruss. The network helps show where H J Gruss may publish in the future.

Co-authorship network of co-authors of H J Gruss

This figure shows the co-authorship network connecting the top 25 collaborators of H J Gruss. A scholar is included among the top collaborators of H J Gruss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H J Gruss. H J Gruss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Glass, Oliver, Ricardo Henao, Keyur Patel, et al.. (2018). Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications. 2(11). 1344–1355. 69 indexed citations
3.
Jones, Oliver, et al.. (2003). Topical methoxamine gel: A potential new treatment for faecal incontinence. Gastroenterology. 124(4). A85–A85. 1 indexed citations
4.
Younes, Anas, Ugo Consoli, Virginia Snell, et al.. (1997). CD30 ligand in lymphoma patients with CD30+ tumors.. Journal of Clinical Oncology. 15(11). 3355–3362. 48 indexed citations
5.
Bangerter, Markus, F. Herrmann, Martin Grießhammer, et al.. (1997). The abundant presence of Söderström bodies in cytology smears of fine-needle aspirates contributes to distinguishing high-grade non-Hodgkin's lymphoma from carcinoma and sarcoma. Annals of Hematology. 74(4). 175–178. 13 indexed citations
6.
Gruss, H J, Antonio Pinto, Annunziata Gloghini, et al.. (1996). CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.. PubMed. 149(2). 469–81. 67 indexed citations
7.
Younes, Anas, Ugo Consoli, Shourong Zhao, et al.. (1996). CD30 ligand is expressed on resting normal and malignant human B lymphocytes. British Journal of Haematology. 93(3). 569–571. 55 indexed citations
8.
Meierhoff, Guido, H J Gruss, Olivier Rosnet, et al.. (1995). Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.. PubMed. 9(8). 1368–72. 92 indexed citations
9.
Brasel, Kenneth, et al.. (1995). Expression of the flt3 receptor and its ligand on hematopoietic cells.. PubMed. 9(7). 1212–8. 97 indexed citations
10.
Gruss, H J, et al.. (1994). Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.. PubMed. 8(12). 2083–94. 53 indexed citations
11.
12.
Gruss, H J, et al.. (1992). Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.. Molecular Pharmacology. 42(1). 63–68. 28 indexed citations
13.
Brach, MA, H J Gruss, Yasunari Asano, et al.. (1992). Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.. PubMed. 52(8). 2197–201. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026